Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Repositório Institucional da UNESP |
Texto Completo: | http://dx.doi.org/10.3390/pharmaceutics14040755 http://hdl.handle.net/11449/239889 |
Resumo: | Gastric ulcer is one of the most frequent gastrointestinal disorders, and there is an increasing search for natural products that can heal ulcers and avoid their recurrence. We aimed to evaluate the gastroprotective activity of vanillin, including the investigation of anti-inflammatory activity and the modulation of gene expression. Wistar rats were orally treated with vehicle, carbenoxolone, or vanillin (25, 50, or 100 mg/kg) and orally received absolute ethanol to develop gastric ulcers. We analyzed the ulcer area, conducted histological analysis, and measured the levels of the inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ, and anti-inflammatory cytokine IL-10 by ELISA. We analyzed mRNA expression for NF-κB, TNF-α, and Il-10. We measured NOx levels using the Griess reaction. Our results showed similar gastroprotection for the three doses. Vanillin increased mucus production and preserved gastric mucosa integrity. The gastroprotective effect was linked to anti-inflammatory activity as a result of decreasing the levels of TNF-α, IL-6, IL-1β, and IFN-γ and increasing IL-10 levels. Vanillin downregulated the mRNA expression of NF-κB and TNF-α, upregulated the mRNA expression of Il-10, and increased NOx levels in the stomach. The gastroprotective activity of vanillin is related to the maintenance of gastric mucus and the local inflammatory response modulation. |
id |
UNSP_2f3f4ddb828cfcef290b0197fa9bf6ec |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/239889 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer FormationELISAIFN-γIL-1βinflammationNF-κBNOqPCRstomachTNF-αvanillinGastric ulcer is one of the most frequent gastrointestinal disorders, and there is an increasing search for natural products that can heal ulcers and avoid their recurrence. We aimed to evaluate the gastroprotective activity of vanillin, including the investigation of anti-inflammatory activity and the modulation of gene expression. Wistar rats were orally treated with vehicle, carbenoxolone, or vanillin (25, 50, or 100 mg/kg) and orally received absolute ethanol to develop gastric ulcers. We analyzed the ulcer area, conducted histological analysis, and measured the levels of the inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ, and anti-inflammatory cytokine IL-10 by ELISA. We analyzed mRNA expression for NF-κB, TNF-α, and Il-10. We measured NOx levels using the Griess reaction. Our results showed similar gastroprotection for the three doses. Vanillin increased mucus production and preserved gastric mucosa integrity. The gastroprotective effect was linked to anti-inflammatory activity as a result of decreasing the levels of TNF-α, IL-6, IL-1β, and IFN-γ and increasing IL-10 levels. Vanillin downregulated the mRNA expression of NF-κB and TNF-α, upregulated the mRNA expression of Il-10, and increased NOx levels in the stomach. The gastroprotective activity of vanillin is related to the maintenance of gastric mucus and the local inflammatory response modulation.Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Department of Structural and Functional Biology Institute of Biosciences São Paulo State University (UNESP), Dr Antonio Celso W Zanin Street 250Department of Structural and Functional Biology Institute of Biosciences São Paulo State University (UNESP), Dr Antonio Celso W Zanin Street 250FAPESP: 2018/11484-2Universidade Estadual Paulista (UNESP)Ciciliato, Murilo Piologo [UNESP]Souza, Matheus Chiaradia de [UNESP]Tarran, Carolina Mendes [UNESP]Castilho, Ana Laura Tironi de[UNESP]Vieira, Ana Júlia [UNESP]Rozza, Ariane Leite [UNESP]2023-03-01T19:51:59Z2023-03-01T19:51:59Z2022-04-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.3390/pharmaceutics14040755Pharmaceutics, v. 14, n. 4, 2022.1999-4923http://hdl.handle.net/11449/23988910.3390/pharmaceutics140407552-s2.0-85128260758Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengPharmaceuticsinfo:eu-repo/semantics/openAccess2023-03-01T19:51:59Zoai:repositorio.unesp.br:11449/239889Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T13:41:58.539177Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation |
title |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation |
spellingShingle |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation Ciciliato, Murilo Piologo [UNESP] ELISA IFN-γ IL-1β inflammation NF-κB NO qPCR stomach TNF-α vanillin |
title_short |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation |
title_full |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation |
title_fullStr |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation |
title_full_unstemmed |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation |
title_sort |
Anti-Inflammatory Effect of Vanillin Protects the Stomach against Ulcer Formation |
author |
Ciciliato, Murilo Piologo [UNESP] |
author_facet |
Ciciliato, Murilo Piologo [UNESP] Souza, Matheus Chiaradia de [UNESP] Tarran, Carolina Mendes [UNESP] Castilho, Ana Laura Tironi de[UNESP] Vieira, Ana Júlia [UNESP] Rozza, Ariane Leite [UNESP] |
author_role |
author |
author2 |
Souza, Matheus Chiaradia de [UNESP] Tarran, Carolina Mendes [UNESP] Castilho, Ana Laura Tironi de[UNESP] Vieira, Ana Júlia [UNESP] Rozza, Ariane Leite [UNESP] |
author2_role |
author author author author author |
dc.contributor.none.fl_str_mv |
Universidade Estadual Paulista (UNESP) |
dc.contributor.author.fl_str_mv |
Ciciliato, Murilo Piologo [UNESP] Souza, Matheus Chiaradia de [UNESP] Tarran, Carolina Mendes [UNESP] Castilho, Ana Laura Tironi de[UNESP] Vieira, Ana Júlia [UNESP] Rozza, Ariane Leite [UNESP] |
dc.subject.por.fl_str_mv |
ELISA IFN-γ IL-1β inflammation NF-κB NO qPCR stomach TNF-α vanillin |
topic |
ELISA IFN-γ IL-1β inflammation NF-κB NO qPCR stomach TNF-α vanillin |
description |
Gastric ulcer is one of the most frequent gastrointestinal disorders, and there is an increasing search for natural products that can heal ulcers and avoid their recurrence. We aimed to evaluate the gastroprotective activity of vanillin, including the investigation of anti-inflammatory activity and the modulation of gene expression. Wistar rats were orally treated with vehicle, carbenoxolone, or vanillin (25, 50, or 100 mg/kg) and orally received absolute ethanol to develop gastric ulcers. We analyzed the ulcer area, conducted histological analysis, and measured the levels of the inflammatory cytokines TNF-α, IL-6, IL-1β, and IFN-γ, and anti-inflammatory cytokine IL-10 by ELISA. We analyzed mRNA expression for NF-κB, TNF-α, and Il-10. We measured NOx levels using the Griess reaction. Our results showed similar gastroprotection for the three doses. Vanillin increased mucus production and preserved gastric mucosa integrity. The gastroprotective effect was linked to anti-inflammatory activity as a result of decreasing the levels of TNF-α, IL-6, IL-1β, and IFN-γ and increasing IL-10 levels. Vanillin downregulated the mRNA expression of NF-κB and TNF-α, upregulated the mRNA expression of Il-10, and increased NOx levels in the stomach. The gastroprotective activity of vanillin is related to the maintenance of gastric mucus and the local inflammatory response modulation. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-04-01 2023-03-01T19:51:59Z 2023-03-01T19:51:59Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.3390/pharmaceutics14040755 Pharmaceutics, v. 14, n. 4, 2022. 1999-4923 http://hdl.handle.net/11449/239889 10.3390/pharmaceutics14040755 2-s2.0-85128260758 |
url |
http://dx.doi.org/10.3390/pharmaceutics14040755 http://hdl.handle.net/11449/239889 |
identifier_str_mv |
Pharmaceutics, v. 14, n. 4, 2022. 1999-4923 10.3390/pharmaceutics14040755 2-s2.0-85128260758 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Pharmaceutics |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
|
_version_ |
1808128267696209920 |